Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
Issues related to Medicare Advantage marketing practices;
S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024;
Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice)
Expiring healthcare extenders;
H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42);
H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Duration: April 27, 2009
to
present
General Issues: Medicare/Medicaid , Health Issues , Budget/Appropriations , Taxation/Internal Revenue Code , Insurance
Spending: about $2,690,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Government Accountability Office (GAO), U.S. Senate,, Centers For Medicare and Medicaid Services (CMS),, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Amy Tejral
Legislative Director, Senator Ben Nelson
Tracy Spicer
Dep.Chief of Staff, Sen. Edward Kennedy
Political Director, Sen. Edward M. Kennedy
Legislative Assistant, Sen. Edward M. Kennedy
Special Assistant, Sen Edward M Kennedy
Staff Assistant, Sen. Edward M. Kennedy
Dep.Chief of Staff, Sen. Edward M. Kennedy
Elizabeth Barnett
Legislative Assistant, Sen. Blanche Lincoln
Speechwriter, Sen. Blanche Lincoln
Legislative Correspondent, Sen. Blanche Lincoln
Staff Assist., Senate Energy & Natural Re. Com.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on April 22.
Original Filing: 301574293.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
Issues related to Medicare Advantage marketing practices;
S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024;
Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expiring healthcare extenders;
H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42);
H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Jan. 22.
Original Filing: 301539388.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
Cassidy draft legislation on dual eligible beneficiaries;
Issues related to Medicare Advantage marketing practices
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expiring healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Oct. 20, 2023.
Original Filing: 301511316.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
Cassidy draft legislation on dual eligible beneficiaries;
Issues related to Medicare Advantage marketing practices
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2023
In Q2, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on July 19, 2023.
Original Filing: 301484118.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
Cassidy draft legislation on dual eligible beneficiaries;
Contract Year 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F);
CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2023
In Q1, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301464500.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Telehealth extension;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
Cassidy/Scott RFI on dual eligible beneficiaries;
Contract Year 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F);
CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
H.J.Res.7, terminating the national emergency related to the COVID-19 pandemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Jan. 20, 2023.
Original Filing: 301439905.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies;
Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage;
S. 4264, Advancing Integration in Medicare and Medicaid (AIM) Act;
S. 4273, Supporting States in Integrating Care Act of 2022;
S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021;
CMS RFI on Medicare Advantage;
Cassidy/Scott RFI on dual eligible beneficiaries;
Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule CMS-4201-P
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 2617, Consolidated Appropriations Act, 2023 - extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Senate Finance Committee bipartisan Discussion Draft: The Mental Health Parity;
Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Issues related to the Public Health Emergency;
S. 4293, Pharmacy Benefit Manager Transparency Act of 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413967.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies;
Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage;
S. 4264, Advancing Integration in Medicare and Medicaid (AIM) Act;
S. 4273, Supporting States in Integrating Care Act of 2022;
S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021;
CMS RFI on Medicare Advantage
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to H.R. 5376, Inflation Reduction Act of 2022 (now PL 117-169) and implementation;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Issues related to the Public Health Emergency;
Issues related to the FY 2023 Presidents Budget;
S. 4293, Pharmacy Benefit Manager Transparency Act of 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301393861.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies;
Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage;
S.4264, Advancing Integration in Medicare and Medicaid (AIM) Act;
S.4273, Supporting States in Integrating Care Act of 2022;
S.3018/HR.3173, Improving Seniors Timely Access to Care Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
H.R. 5376, Build Back Better Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Issues related to the Public Health Emergency;
Issues related to the FY 2023 Presidents Budget;
S.4293, Pharmacy Benefit Manager Transparency Act of 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on April 20, 2022.
Original Filing: 301371718.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Extension of the Medicare Sequester;
S. 748, Medicare Sequester Relief Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies
Lobbying Issues
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
S. 2210, Better Care Better Jobs Act;
H.R. 5376, Build Back Better Act;
Consolidated Appropriations Act, 2022 (PL 117-103);-
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Issues related to the Public Health Emergency;
H.R. 7007, COVID Supplemental Appropriations Act, 2022;
Issues related to the FY 2023 Presidents Budget
4th Quarter, 2021
In Q4, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Jan. 19, 2022.
Original Filing: 301330254.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments;
CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies;
PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo
Lobbying Issues
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
S. 2210, Better Care Better Jobs Act;
H.R. 5376, Build Back Better Act;
PL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester)
3rd Quarter, 2021
In Q3, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301314077.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs;
Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
Senate HELP and Energy & Commerce Public Option RFI;
S. 2210, Better Care Better Jobs Act;
H.R. 5376, Build Back Better Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2021
In Q2, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301290202.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Drug pricing proposals and impact to SNP plans serving beneficiaries with high-cost drugs
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services;
Senate HELP and Energy & Commerce Public Option RFI;
S. 2210, Better Care Better Jobs Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2021
In Q1, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on April 20, 2021.
Original Filing: 301262609.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 1319, American Rescue Plan Act of 2021 (PL 117-2);
Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1319, American Rescue Plan Act of 2021 (PL 117-2);
Continued monitoring of implementation of Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (PL 116-123);
Continued monitoring of implementation of Families First Coronavirus Response Act (PL 116-127);
Continued monitoring of implementation of CARES Act (PL 116-136) - proposals related to physician and provider relief
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2020
In Q4, Avenue Solutions lobbied for SNP Alliance, Inc. , earning $50,000. The report was filed on Jan. 21, 2021.
Original Filing: 301244303.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019;
Public Law 116-136, CARES Act; telehealth issues related to COVID-19, particularly audio-only flexibilities;
H.R. 925, The Heroes Act;
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act (Public Law 116-159);
H.R. 7659, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020;
Extension of the Medicare Sequester;
H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)
Lobbying Issues
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
H.R. 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform)
3rd Quarter, 2020
In Q3, Avenue Solutions lobbied for SNP Alliance, Inc. (formerly National Health Policy Group obo SNP Alliance) , earning $50,000. The report was filed on Oct. 20, 2020.
Original Filing: 301223273.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019;
Public Law 116-136, CARES Act; telehealth issues related to COVID-19, particularly audio-only flexibilities;
H.R. 925, The Heroes Act;
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; Public Law 116-159
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
H.R. 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
Telehealth issues related to COVID-19, particularly audio-only flexibilities
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, Avenue Solutions lobbied for SNP Alliance, Inc. (formerly National Health Policy Group obo SNP Alliance) , earning $50,000. The report was filed on July 20, 2020.
Original Filing: 301201355.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019;
Public Law 116-136, CARES Act - telehealth issues related to COVID-19, particularly audio-only flexibilities
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief; telehealth issues related to COVID-19;
H.R, 6800, HEROES Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
Telehealth issues related to COVID-19, particularly audio-only flexibilities
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2020
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on April 17, 2020.
Original Filing: 301170233.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019;
H.R. 748 - (Public Law 116-136) - CARES Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2019
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on Jan. 18, 2020.
Original Filing: 301120973.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068913.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on July 19, 2019.
Original Filing: 301052704.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 3461, Community-Based Independence for Seniors Act of 2019
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2019
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on April 19, 2019.
Original Filing: 301031189.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Discussions around reintroduction of H.R. 4006/ S. 309, Community-Based Independence for Seniors Act from 115th Congress
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2018
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on Jan. 21, 2019.
Original Filing: 301012221.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 4006, Community-Based Independence for Seniors Act of 2017
S. 309, Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2018
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990408.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 4006, Community-Based Independence for Seniors Act of 2017
S. 309, Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2018
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on July 19, 2018.
Original Filing: 300970658.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
H.R. 4006, Community-Based Independence for Seniors Act of 2017
S. 309, Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2018
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on April 19, 2018.
Original Filing: 300951047.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization;
S. 870, CHRONIC Care Act of 2017;
H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes;
2018 Medicare Advantage and Part D Payment Policies Final Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies;
H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018;
H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2017
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $40,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936574.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization;
S. 870, CHRONIC Care Act of 2017;
H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to year-end healthcare discussions/offsets for budget deal and healthcare extender policies
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2017
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $40,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905516.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization;
S. 870, CHRONIC Care Act of 2017;
H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2017
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on July 19, 2017.
Original Filing: 300888809.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization;
S. 870, CHRONIC Care Act of 2017
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2017
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance) , earning $50,000. The report was filed on April 20, 2017.
Original Filing: 300875201.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization and permanency;
Senate Finance Committee's Chronic Care Working Group;
2018 Medicare Advantage & Part D Rate Notice & Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2016
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Jan. 23, 2017.
Original Filing: 300856044.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization and permanency;
H.R. 6, 21st Century Cures Act;
Senate Finance Committee's Chronic Care Working Group
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2016
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $30,000. The report was filed on Oct. 20, 2016.
Original Filing: 300836898.xml
Lobbying Issues
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization and permanency
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2016
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $30,000. The report was filed on July 19, 2016.
Original Filing: 300814207.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization and permanency
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2016
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $30,000. The report was filed on April 20, 2016.
Original Filing: 300799617.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization and permanency;
Medicare Advantage CY2017 Call Letter & Rate Notice
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2015
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $20,000. The report was filed on Jan. 20, 2016.
Original Filing: 300778701.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SNP (Special Needs Plans) reauthorization and permanency;
Social determinants of health research/Medicare Advantage Star Ratings program;
S.2104, A bill to amend title XVIII of the Social Security Act to provide relief to Medicare Advantage plans with a significant number of dually eligible or low-income subsidy beneficiaries and to prevent the termination of two star plans
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2015
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $20,000. The report was filed on Oct. 20, 2015.
Original Filing: 300762987.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization and permanency;
social determinants of health research/Medicare Advantage Star Ratings program;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2015
Avenue Solutions amended a lobbying report for representation of National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) in Q22015 on Nov. 3, 2015.
Original Filing: 300767110.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;
social determinants of health research/Medicare Advantage Star Ratings program;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SGR repeal - H.R. 2, Medicare Access & CHIP Reauthorization Act of 2015;
2016 Medicare Advantage and Part D Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2015
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on July 17, 2015.
Original Filing: 300737897.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;
social determinants of health research/Medicare Advantage Star Ratings program;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SGR repeal - H.R. 2, Medicare Access & CHIP Reauthorization Act of 2015;
2016 Medicare Advantage and Part D Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2015
Avenue Solutions amended a lobbying report for representation of National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) in Q12015 on Nov. 3, 2015.
Original Filing: 300767109.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;
social determinants of health research/Medicare Advantage Star Ratings program;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SGR repeal - H.R. 2, Medicare Access & CHIP Reauthorization Act of 2015;
2016 Medicare Advantage and Part D Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2015
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on April 20, 2015.
Original Filing: 300724793.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;
social determinants of health research/Medicare Advantage Star Ratings program;
SES (socio-economic status) issues related to SNP payment rates and quality measures;
SGR repeal - H.R. 2, Medicare Access & CHIP Reauthorization Act of 2015;
2016 Medicare Advantage and Part D Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2014
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Jan. 20, 2015.
Original Filing: 300707900.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;
social determinants of health research/Medicare Advantage Star Ratings program;
S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2014
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Oct. 18, 2014.
Original Filing: 300681863.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;
social determinants of health research;
S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on July 20, 2014.
Original Filing: 300663818.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorization;Cuts to Medicare Advantage plans;
Social determinants of health research;
H.R. 4302, Protecting Access to Medicare Act of 2014;
S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2014
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on April 21, 2014.
Original Filing: 300646236.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorizationMedPAC recommendations on SNP reauthorization (I-SNP, D-SNP, C-SNP);
Cuts to Medicare Advantage plans;
Social determinants of health research;
H.R. 4302, Protecting Access to Medicare Act of 2014;
S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
4th Quarter, 2013
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Jan. 21, 2014.
Original Filing: 300625684.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorizationMedPAC recommendations on SNP reauthorization;
Cuts to Medicare Advantage plans;
Chronic care
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
3rd Quarter, 2013
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Oct. 21, 2013.
Original Filing: 300607427.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorizationMedPAC recommendations on SNP reauthorization;
Cuts to Medicare Advantage plans
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
2nd Quarter, 2013
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on July 22, 2013.
Original Filing: 300586564.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorizationMedPAC recommendations on SNP reauthorization
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
1st Quarter, 2013
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on April 22, 2013.
Original Filing: 300564463.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model;
Medicare and Medicaid dual eligible integration;
Performance evaluation/quality oversight;
SNP (Special Needs Plans) reauthorizationMedPAC recommendations on SNP reauthorization
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
4th Quarter, 2012
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Jan. 22, 2013.
Original Filing: 300542679.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model; Medicare and Medicaid dual eligible integration; performance evaluation/quality oversight; SNP (Special Needs Plans) reauthorization
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Debt ceiling, sequestration, fiscal cliff discussions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $50,000. The report was filed on Oct. 21, 2012.
Original Filing: 300516229.xml
Lobbying Issues
Medicare Advantage/CMS-Hierarchical Condition Category Risk Assessment (CMS-HCC RA) payment model; Medicare and Medicaid dual eligible integration; performance evaluation/quality oversight; SNP (Special Needs Plans) reauthorization
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Debt ceiling, sequestration, fiscal cliff discussions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on July 20, 2012.
Original Filing: 300499285.xml
Lobbying Issues
Frailty adjuster; Medicare Advantage payment; Medicare and Medicaid dual eligible integration; performance evaluation; SNP (Special Needs Plans) reauthorization
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
1st Quarter, 2012
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on April 20, 2012.
Original Filing: 300475490.xml
Lobbying Issues
Frailty adjuster; Medicare Advantage payment; Medicare Advantage Star Quality Rating System; Medicare and Medicaid dual eligible integration
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
4th Quarter, 2011
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on Jan. 20, 2012.
Original Filing: 300452610.xml
Lobbying Issues
Frailty adjuster; Medicare Advantage payment; Medicare Advantage Star Quality Rating System; Medicare and Medicaid dual eligible integration; open enrollment period for Medicare Advantage; risk adjustment data validation (RAD-V) audits
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
3rd Quarter, 2011
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on Oct. 20, 2011.
Original Filing: 300424101.xml
Lobbying Issues
Frailty adjuster; Medicare Advantage payment; Medicare Advantage Star Quality Rating System; Medicare and Medicaid dual eligible integration; open enrollment period for Medicare Advantage; risk adjustment data validation (RAD-V) audits
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
2nd Quarter, 2011
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on July 19, 2011.
Original Filing: 300398848.xml
Lobbying Issues
Frailty adjuster; Medicare Advantage payment; Medicare Advantage Star Quality Rating System; Medicare and Medicaid integration; Medicare reimbursement for diagnostic imaging services; open enrollment period for Medicare Advantage; risk adjustment data validation (RADV); issues relating to debt ceiling
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
1st Quarter, 2011
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on April 20, 2011.
Original Filing: 300380200.xml
Lobbying Issues
Medicare Advantage Star Quality Rating System; frailty adjuster; Medicare Advantage payment; Medicare and Medicaid integration
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 4, Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011, issues relating to offset of repeal of 1099 reporting
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on Jan. 19, 2011.
Original Filing: 300343836.xml
Lobbying Issues
Medicare Advantage Star Quality Rating System; frailty adjuster; Medicare Advantage payment; Medicare and Medicaid integration
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
3rd Quarter, 2010
In Q3, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on Oct. 20, 2010.
Original Filing: 300329156.xml
Lobbying Issues
Implementation of healthcare reform, including issues relating to medical loss ratio, preventive services, rate review, claims and appeals, exchanges, Star Quality Rating System, frailty adjuster
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
Medicare Advantage Star Quality Rating System; frailty adjuster
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2010
In Q2, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $40,000. The report was filed on July 20, 2010.
Original Filing: 300303269.xml
Lobbying Issues
H.R. 3590 / PL 111-148/152, Patient Protection and Affordable Care Act - Medicare Advantage, frailty adjuster, maximum out-of-pocket limits, star rating system/bonus payments, Federal Coordinated Health Care Office;
H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
1st Quarter, 2010
In Q1, Avenue Solutions lobbied for National Health Policy Group (on behalf of SNP Alliance, an NHPG initiative) , earning $30,000. The report was filed on April 19, 2010.
Original Filing: 300266868.xml
Lobbying Issues
HR 2758, Medicare Specialty Care Improvement and Protection Act - Medicare Advantage, special needs plans;
HR 3200, America's Affordable Health Choices Act - Medicare Advantage, special needs plans, Medicare FFS payment reform;
HR 3590, Patient Protection and Affordable Care Act - Medicare Advantage, special needs plans, Medicare FFS payment reform;HR 3962, Affordable Health Care for America Act - Medicare Advantage, special needs plans, Medicare FFS payment reform;
HR 4213, Tax Extenders Act - Medicare Advantage, special needs plans, Medicare physician payment;
HR 4872, Health Care and Education Reconciliation Act - changes to Medicare Advantage funding;
S 1307, Medicare Specialty Care Improvement and Protection Act - Medicare Advantage, special needs plans;
S 1796, America's Healthy Future Act - Medicare Advantage, special needs plans, Medicare FFS payment reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Executive Office of the President (EOP)
Lobbying Issues
HR 3590, Patient Protection and Affordable Care Act - premium tax;
HR 4872, Health Care and Education Reconciliation Act - changes to premium tax;
S 1796, America's Healthy Future Act - high-cost health plan tax, industry tax
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Executive Office of the President (EOP)
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, Avenue Solutions lobbied for National Health Policy Group , earning $30,000. The report was filed on Jan. 20, 2010.
Original Filing: 300247868.xml
Lobbying Issues
S. 1796 Americas Healthy Future Act (Baucus); H.R. 3962 Americas Affordable Health Choices Act (Dingell) Changes to Medicare Advantage/Special Needs plans under healthcare reform; H.R. 2758, Medicare Specialty Care Improvement and Protection Act (Kind) Medicare Advantage special needs plans; S. 1307, Medicare Specialty Care Improvement and Protection Act (Feingold); H.R.3590 The Patient Protection and Affordable Care Act (Reid managers amendment).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) White House Office
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2009
In Q3, Avenue Solutions lobbied for National Health Policy Group , earning $30,000. The report was filed on Oct. 20, 2009.
Original Filing: 300215437.xml
Lobbying Issues
Americas Healthy Future Act (Baucus)/HR 3200 Americas Affordable Health Choices Act (Dingell) Changes to Medicare Advantage/Special Needs plans under healthcare reform; H.R. 2758, Medicare Specialty Care Improvement and Protection Act (Kind) Medicare Advantage special needs plans; S. 1307, Medicare Specialty Care Improvement and Protection Act (Feingold)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) White House Office
Type of Issue
Medicare/Medicaid Health Issues
2nd Quarter, 2009
In Q2, Avenue Solutions lobbied for National Health Policy Group , earning $30,000. The report was filed on July 16, 2009.
Original Filing: 300180897.xml
Lobbying Issues
Senate Finance Committee Draft Policy Options (Baucus-Grassley) Medicare Advantage funding, special needs plans, Medicare FFS payment reform; S. 1307 Medicare Specialty Care Improvement and Protection Act (Feingold) Medicare Advantage Special Need Plans; House Tri-Committee Discussion Draft for Health Reform (Waxman, Rangel, Miller) Medicare Advantage funding, special needs plans; HR 2758 Medicare Specialty Care Improvement and Protection Act (Kind) Medicare Advantage special needs plans; S.Con.Res. 13 Budget Resolution (Conrad) Medicare Advantage funding; H.Con.Res. 85 Budget Resolution (Spratt) health-related provisions.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) White House Office
Lobbying Issues
Changes to Medicare Advantage/Special Need Plans under healthcare reform. S. 1307; HR 2758; HELP Committee Affordable Choices Act, Finance Committee Options Papers on Delivery System, Coverage and Financing and the House Tri-Committee Draft on Health Care Reform.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) White House Office
2nd Quarter, 2009
Avenue Solutions filed a lobbying registration on May 17, 2009 to represent National Health Policy Group, effective April 27, 2009.
Original Filing: 300169440.xml
Issue(s) they said they’d lobby about: Changes to Medicare Advantage/Special Need Plans under healthcare reform. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate